X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs UNICHEM LAB - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD UNICHEM LAB ALEMBIC LTD/
UNICHEM LAB
 
P/E (TTM) x 63.8 55.6 114.7% View Chart
P/BV x 2.6 0.6 427.1% View Chart
Dividend Yield % 0.4 2.3 17.2%  

Financials

 ALEMBIC LTD   UNICHEM LAB
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
UNICHEM LAB
Mar-19
ALEMBIC LTD/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs72292 24.7%   
Low Rs34182 18.6%   
Sales per share (Unadj.) Rs4.7167.7 2.8%  
Earnings per share (Unadj.) Rs6.1-3.6 -168.1%  
Cash flow per share (Unadj.) Rs6.25.9 105.1%  
Dividends per share (Unadj.) Rs0.204.00 5.0%  
Dividend yield (eoy) %0.41.7 22.4%  
Book value per share (Unadj.) Rs40.7372.3 10.9%  
Shares outstanding (eoy) m267.0370.38 379.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x11.31.4 796.9%   
Avg P/E ratio x8.7-65.3 -13.3%  
P/CF ratio (eoy) x8.539.9 21.3%  
Price / Book Value ratio x1.30.6 204.5%  
Dividend payout %3.3-110.2 -3.0%   
Avg Mkt Cap Rs m14,13916,680 84.8%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m2072,393 8.7%   
Avg. sales/employee Rs ThNM4,535.2-  
Avg. wages/employee Rs ThNM919.8-  
Avg. net profit/employee Rs ThNM-98.2-  
INCOME DATA
Net Sales Rs m1,25511,801 10.6%  
Other income Rs m370984 37.6%   
Total revenues Rs m1,62512,785 12.7%   
Gross profit Rs m111-835 -13.3%  
Depreciation Rs m38674 5.6%   
Interest Rs m275 2.3%   
Profit before tax Rs m442-600 -73.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2121 173,142.9%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24-343 -7.0%   
Profit after tax Rs m1,630-256 -637.8%  
Gross profit margin %8.9-7.1 -125.1%  
Effective tax rate %5.457.3 9.5%   
Net profit margin %129.8-2.2 -5,996.4%  
BALANCE SHEET DATA
Current assets Rs m1,86720,384 9.2%   
Current liabilities Rs m5915,029 11.8%   
Net working cap to sales %101.6130.1 78.1%  
Current ratio x3.24.1 77.9%  
Inventory Days Days94105 90.0%  
Debtors Days Days74135 54.5%  
Net fixed assets Rs m1,7919,023 19.8%   
Share capital Rs m534141 379.3%   
"Free" reserves Rs m10,32426,058 39.6%   
Net worth Rs m10,85826,199 41.4%   
Long term debt Rs m410-   
Total assets Rs m11,59131,496 36.8%  
Interest coverage x260.9-7.0 -3,740.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.10.4 28.9%   
Return on assets %14.1-0.6 -2,458.6%  
Return on equity %15.0-1.0 -1,539.1%  
Return on capital %15.2-2.0 -759.7%  
Exports to sales %1.569.4 2.2%   
Imports to sales %21.00-   
Exports (fob) Rs m198,188 0.2%   
Imports (cif) Rs m263NA-   
Fx inflow Rs m198,188 0.2%   
Fx outflow Rs m264596 44.3%   
Net fx Rs m-2447,592 -3.2%   
CASH FLOW
From Operations Rs m236-3,278 -7.2%  
From Investments Rs m-224-2,860 7.8%  
From Financial Activity Rs m-27-24 109.9%  
Net Cashflow Rs m-15-4,690 0.3%  

Share Holding

Indian Promoters % 64.0 50.1 127.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 15.1 1.3%  
FIIs % 9.7 3.0 323.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 31.7 82.3%  
Shareholders   54,701 20,176 271.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT  ABBOTT INDIA  PLETHICO PHARMA  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Falling Stocks, Tumbling Rupee and Weakening Economy(Podcast)

Another week of slowdown in the markets over fears of a looming slowdown in the domestic and global economy continue.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Interest Rates Are Low. Buy Solid Dividend Stocks Instead(The 5 Minute Wrapup)

Aug 13, 2019

The dividends paid by these stocks are helpful when interest rates are falling.

Smallcaps that Will Outperform in the Market Rebound(Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

My Top 3 Dividend Stocks to Buy Now(Profit Hunter)

Aug 19, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Chandrayaan 2 Heads to the Moon and It's Good News for These Stocks(The 5 Minute Wrapup)

Aug 14, 2019

Why investors should take note of India's advantage as a low cost satellite launcher...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 23, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS